Preservation of cochlear function in Cd39 deficient mice

被引:3
|
作者
Vlajkovic, Srdjan M. [1 ]
Housley, Gary D. [1 ]
Thorne, Peter R. [1 ,2 ]
Gupta, Rita [1 ]
Enjyoji, Keiichi [3 ]
Cowan, Peter J. [4 ,5 ]
Liberman, M. Charles [6 ]
Robson, Simon C. [3 ]
机构
[1] Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland 1142, New Zealand
[2] Univ Auckland, Fac Med & Hlth Sci, Discipline Audiol, Auckland 1142, New Zealand
[3] Harvard Univ, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[4] Univ Melbourne, St Vincents Hosp Melbourne, Immunol Res Ctr, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
[6] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA
关键词
CD39; NTPDase1; Ectonucleotidase; Purinergic signalling; Knockout mice; Hearing; NUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE-1; UP-REGULATION; CATALYTIC PROPERTIES; ECTONUCLEOTIDASES; PROTECTION; EXPRESSION; ADENOSINE; NTPDASE1; CELLS; IDENTIFICATION;
D O I
10.1016/j.heares.2009.03.009
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
Signalling actions of extracellular nucleotides via P2 receptors influence cellular function in most tissues. In the inner ear, P2 receptor signaling is involved in many processes including the regulation of hearing sensitivity and the cochlea's response to noise stress. CD39 (NTPDase1/ENTPD1) is an ectonucleotidase (ecto-nucleoside triphosphate diphosphohydrolase) that can hydrolyse purine and pyrimidine nucleoside tri- and di-phosphates to generate monophosphate nucleosides. Mice null for Cd39 exhibit major alterations in haemostasis and profound alterations in inflammatory and thrombotic reactions. Studies in the cochlea have suggested the involvement of purinergic-type signals that could be modulated by CD39 in regulation of cochlear blood flow and also auditory neurotransmission. This study aimed to determine the auditory phenotype of adult Cd39 null mice on the C57BL6 background. Auditory brainstem responses (ABR) and distortion product otoacoustic emissions (DPOAE) were unaffected in Cd39-deficient mice across the range of test frequencies, suggesting normal neural and outer hair cell function. Mutant mice also showed little difference to wild type mice in vulnerability to acoustic trauma. Gene expression analysis of other membrane-bound NTPDases with comparable hydrolytic activity demonstrated an up-regulation of Entpd2 and Entpd8 in the cochleae of Cd39 deficient mice. These findings suggest that Cd39 deletion alone does not adversely affect cochlear function, possibly as compensatory up-regulation of other surface located NTPDases may offset predicted alterations in cochlear homeostasis. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 82
页数:6
相关论文
共 50 条
  • [1] Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice
    De Giorgi, Marco
    Enjyoji, Keiichi
    Jiang, Gordon
    Csizmadia, Eva
    Mitsuhashi, Shuji
    Gumina, Richard J.
    Smolenski, Ryszard T.
    Robson, Simon C.
    JOURNAL OF LIPID RESEARCH, 2017, 58 (07) : 1292 - 1305
  • [2] Structure and function of ectoapyrase (CD39)
    Wang, TF
    Handa, M
    Guidotti, G
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (3-4) : 245 - 252
  • [3] Attenuated allergic airway inflammation in Cd39 null mice
    Idzko, M.
    Ayata, C. K.
    Mueller, T.
    Duerk, T.
    Grimm, M.
    Baudiss, K.
    Vieira, R. P.
    Cicko, S.
    Boehlke, C.
    Zech, A.
    Sorichter, S.
    Pelletier, J.
    Sevigny, J.
    Robson, S. C.
    ALLERGY, 2013, 68 (04) : 472 - 480
  • [4] Suppression of Atherosclerosis by CD39
    Kanthi, Yogendra
    Hyman, Matthew
    Liao, Hui
    Baek, Amy
    Visovatti, Scott
    Sutton, Nadia
    Takabe, Wakako
    Ni, Chih-Wen
    Jo, Hanjoong
    Pinsky, David
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [5] CD39 target practice
    Newman, Debra K.
    BLOOD, 2013, 121 (16) : 3061 - 3062
  • [6] Therapeutic potential of CD39
    Robson, Simon C.
    PURINERGIC SIGNALLING, 2018, 14 : S4 - S4
  • [7] Targeting CD39 in cancer
    Moesta, Achim K.
    Li, Xian-Yang
    Smyth, Mark J.
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (12) : 739 - 755
  • [8] Targeting CD39 in cancer
    Achim K. Moesta
    Xian-Yang Li
    Mark J. Smyth
    Nature Reviews Immunology, 2020, 20 : 739 - 755
  • [9] Hypoxic CD39 Knockout Mice Exhibit Severe Pulmonary Hypertension
    Visovatti, Scott
    Bushart, David
    Anyanwu, Anuli
    Pinsky, David
    CIRCULATION RESEARCH, 2011, 109 (12) : E58 - E58
  • [10] Protection of CD39 Transgenic Mice From Cerebral Ischemic Injury
    Baek, Amy
    Petrovic-Djergovic, Danica
    Liao, Hui
    Ray, Jessica
    Sutton, Nadia
    Kanthi, Yogendra
    Pinsky, David
    CIRCULATION, 2013, 128 (22)